FIELD: medicine.
SUBSTANCE: invention relates to medicine, and deals with transcutaneous medication for treatment of Parkinson disease, which contains combination of at least two active substances.
EFFECT: invention ensures supradditive addition of substances effect, harmonised and mutually adapted levels of concentration of separate components of active substances, increased safety of combined therapy.
11 cl
Authors
Dates
2010-08-27—Published
2004-08-14—Filed